Hidradenitis Suppurativa - 19 Studies Found
RECRUITING |
: A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : 1 mL extractable volume of 150 mg/mL SAR442970 filled in 2 mL glass vial |
RECRUITING |
: Physical Activity in Hidradenitis Suppurativa (HS) : Hidradenitis Suppurativa : 2024-11-10 : Participants will perform a minimum of one exercise from each of the targeted muscle groups at a frequency of every other day, for a total of 3-4 days |
RECRUITING |
: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : Oral Tablet |
RECRUITING |
: Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). : Hidradenitis Suppurativa : 2024-11-10 : Deucravacitinib is a stable deuterium-containing compound (where deuterium is a stable, nonradioactive isotope of hydrogen) and a potent, highly selec |
RECRUITING |
: Mindfulness in Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : The MBSR course will consist of weekly sessions lasting two and a half hours, involving lecture, meditation, and self-reflection.Mindfulness |
RECRUITING |
: A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : Administered SC |
RECRUITING |
: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) : Hidradenitis Suppurativa (HS) : 2024-11-10 : Oral, Tablet |
RECRUITING |
: Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : Spesolimab Formulation 1 |
COMPLETED |
: Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa : Hidradenitis Suppurativa : 2024-11-10 : Ruxolitinib cream is a topical formulation applied as a thin film to affected areas. |